Disc Medicine, Inc
Clinical trials sponsored by Disc Medicine, Inc, explained in plain language.
-
New drug aims to reduce Blood-Letting in rare blood cancer
Disease control Recruiting nowThis study tests an experimental drug called DISC-3405 in 60 adults with polycythemia vera (PV), a condition where the body makes too many red blood cells. The goal is to see if the drug is safe and can reduce the need for regular blood removal (phlebotomy). Participants will rec…
Phase: PHASE2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New drug aims to free blood cancer patients from transfusions
Disease control Recruiting nowThis study is testing an experimental drug called DISC-0974 in about 150 adults with myelofibrosis or myelodysplastic syndrome (MDS) who also have anemia. The goal is to see if the drug can help patients produce enough red blood cells so they no longer need regular blood transfus…
Phase: PHASE1, PHASE2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated May 12, 2026 13:40 UTC